Catalytic transfer hydrogenation and anticancer activity of arene–ruthenium compounds incorporating bi-dentate precursors

2015 ◽  
Vol 44 (36) ◽  
pp. 16107-16118 ◽  
Author(s):  
Yu-Hsiang Chang ◽  
Wohn-Jenn Leu ◽  
Amitabha Datta ◽  
Hung-Chang Hsiao ◽  
Chia-Her Lin ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Anticancer Activity ◽  
Transfer Hydrogenation ◽  
Hormone Refractory Prostate Cancer ◽  
Catalytic Transfer Hydrogenation ◽  
Ruthenium Compounds ◽  
Catalytic Transfer ◽  
Hormone Refractory

A series of arene–Ru compounds were synthesized and their catalytic transfer hydrogenation and anticancer activity towards human hormone-refractory prostate cancer were investigated.

Half-sandwich Ru(II)(η6-p-cymene) complexes bearing N-dibenzosuberenyl appended thiourea for catalytic transfer hydrogenation and in vitro anticancer activity

Polyhedron ◽  
2018 ◽  
Vol 152 ◽  
pp. 147-154 ◽  
Author(s):  
Gandhaveeti Rohini ◽  
Jebiti Haribabu ◽  
K.N. Aneesrahman ◽  
Nattamai S.P. Bhuvanesh ◽  
Konakanchi Ramaiah ◽  
...  
Keyword(s):  
Anticancer Activity ◽  
Transfer Hydrogenation ◽  
Catalytic Transfer Hydrogenation ◽  
Catalytic Transfer ◽  
Half Sandwich

604: A Phase I Trial of Vaccination of Personalized Peptides for HLA-A2/A24 Positive Patients with Hormone-Refractory Prostate Cancer

2007 ◽  
Vol 177 (4S) ◽  
pp. 202-202
Author(s):  
Hirotsugu Uemura ◽  
Motoyoshi Tanaka ◽  
Shigeya Uejima ◽  
Takafumi Minami ◽  
Kiyohide Fujimoto ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase I ◽  
Phase I Trial ◽  
Hormone Refractory Prostate Cancer ◽  
Hormone Refractory

829: PSA-Flare up in Docetaxel Therapy of Hormone-Refractory Prostate cancer (HRPCA): Incidence and Clinical Impact?

2005 ◽  
Vol 173 (4S) ◽  
pp. 225-225
Author(s):  
Peter Olbert ◽  
Andres J. Schrader ◽  
Axel Hegele ◽  
Zoltan Varga ◽  
Axel Heidenreich ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Clinical Impact ◽  
Hormone Refractory Prostate Cancer ◽  
Hormone Refractory
Sign in / Sign up

Export Citation Format

Share Document